clear cell renal cell carcinoma

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clear Cell Renal Cell Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Lymph Nodes Trial in

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Anchorage, Alaska
  • +828 more
Feb 2, 2023

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Duarte, California
  • +250 more
Jan 27, 2023

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Baltimore, Maryland
  • +16 more
Jan 17, 2023

Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 14, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

Recruiting
  • ccRCC
  • +9 more
  • Oral NKT2152
  • Scottsdale, Arizona
  • +6 more
Oct 17, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
Jan 13, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Clear Cell Renal Cell Carcinoma Trial in Korea, Republic of, United States (X4P-001, axitinib)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +19 more
Sep 20, 2021

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))

Terminated
  • Ewing Sarcoma
  • +10 more
  • Stereotactic Body Radiotherapy (SBRT)
  • Boston, Massachusetts
  • +2 more
Apr 5, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Cabozantinib S-malate
  • +2 more
  • Mobile, Alabama
  • +487 more
Jan 28, 2021

Clear Cell Renal Cell Carcinoma Trial in United States (X4P-001, Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Washington, District of Columbia
  • +3 more
Jul 24, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Bevacizumab
  • +3 more
  • Scottsdale, Arizona
  • +523 more
Mar 5, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Peru, United States

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +558 more
Oct 15, 2018

Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,

Completed
  • Childhood Renal Cell Carcinoma
  • +12 more
  • Doxorubicin Hydrochloride
  • +9 more
  • Birmingham, Alabama
  • +186 more
Jun 22, 2017

Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,

Completed
  • Chromophobe Renal Cell Carcinoma
  • +5 more
  • Bevacizumab
  • +3 more
  • Boston, Massachusetts
  • +4 more
Jan 6, 2015

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014